Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedUpdates the ClinicalTrials.gov page’s displayed site software/revision version from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed in the Record History, reflecting updates to the study record versions.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision history updated: added Revision: v3.4.3 and removed Revision: v3.4.2 from the record history.SummaryDifference0.1%

- Check82 days agoChange DetectedVersion history shows a new revision entry (v3.4.2) and the removal of a government funding notice. These updates are limited to site governance and do not alter the study record data or its substantive content.SummaryDifference0.5%

- Check89 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and status updates; updated the page revision to v3.4.1, replacing the previous v3.4.0 entry.SummaryDifference0.5%

Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.